Intra-Cellular Therapies Inc (ITCI)
76.67
-3.19
(-3.99%)
USD |
NASDAQ |
Apr 17, 16:00
75.00
-1.67
(-2.18%)
After-Hours: 20:00
Intra-Cellular Therapies Profit Margin (Quarterly): -21.73% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -21.73% |
| September 30, 2023 | -19.28% |
| June 30, 2023 | -38.85% |
| March 31, 2023 | -46.50% |
| December 31, 2022 | -50.35% |
| September 30, 2022 | -74.45% |
| June 30, 2022 | -157.2% |
| March 31, 2022 | -207.5% |
| December 31, 2021 | -336.0% |
| September 30, 2021 | -356.0% |
| June 30, 2021 | -361.7% |
| March 31, 2021 | -338.5% |
| December 31, 2020 | -489.4% |
| September 30, 2020 | -748.9% |
| June 30, 2020 | -3.40K% |
| March 31, 2020 | -5.37K% |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 |
| Date | Value |
|---|---|
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | -597.6K% |
| September 30, 2017 | -74.37K% |
| June 30, 2017 | -15.48K% |
| March 31, 2017 | -28.27K% |
| December 31, 2016 | -28.08K% |
| September 30, 2016 | -693.8K% |
| June 30, 2016 | -13.50K% |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | -37.48K% |
| March 31, 2015 | -672.3K% |
| December 31, 2014 | -42.09K% |
| September 30, 2014 | -5.16K% |
| June 30, 2014 | -2.07K% |
| March 31, 2014 | -2.71K% |
| December 31, 2013 | -971.7% |
| September 30, 2013 | -735.3% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-5.37K%
Minimum
Mar 2020
-19.28%
Maximum
Sep 2023
-750.9%
Average
-271.8%
Median
Profit Margin (Quarterly) Benchmarks
| Insmed Inc | -222.3% |
| Fate Therapeutics Inc | -2.63K% |
| ADMA Biologics Inc | -23.88% |
| Rhythm Pharmaceuticals Inc | -171.8% |
| Amylyx Pharmaceuticals Inc | 4.36% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -22.65% |
| Return on Assets | -19.20% |
| Return on Invested Capital | -22.65% |
| Gross Profit Margin (Quarterly) | 91.86% |
| Operating Margin (Quarterly) | -25.93% |
| Return on Net Operating Assets | -100.3% |